Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway.

Onco Targets Ther · 2019 · PMC6756275 · PMID 31571914

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The xenograft mouse model analysis also shows reduced tumor size in the BEZ235 treatment group than MK2206 treatment group, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.